12 min listen
Eagle's Eye View: Day 3 Highlights | TCT 2022
Eagle's Eye View: Day 3 Highlights | TCT 2022
ratings:
Length:
9 minutes
Released:
Sep 19, 2022
Format:
Podcast episode
Description
In this special episode of Eagle’s Eye View, Drs. Deepak Bhatt, Bina Ahmed and Roxana Mehran discuss highlights from Day 3 of the TCT 2022 late-breaking science, including PCSK9 Inhibition, FAVOR III China, and SCAAR. The ACC is providing coverage of the hottest TCT 2022 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC’s Meeting Coverage page and follow the ACC on social media using the hashtag #TCT2022 to join the conversation.
Released:
Sep 19, 2022
Format:
Podcast episode
Titles in the series (94)
Eagle’s Eye View: Day 3 Highlights | TCT 2021: In this special episode of Eagle’s Eye View, Drs. Deepak Bhatt, Roxana Mehran, and George Vetrovec discuss highlights from the hottest clinical trials presented during Day 3 of TCT 2021, including OPT-PEACE, SWISS-APERO, and Intrepid TMVR Early... by Eagle's Eye View: Your Weekly CV Update From ACC.org